Key result
SMC Abca1/Abcg1 deficiency drives ~20-fold bladder distension without altering atherosclerosis in mice.
Why the study?
Does SMC-specific Abca1/Abcg1 deficiency affect vasoconstriction and atherosclerosis in Ldlr-/- mice?
Does SMC-specific Abca1/Abcg1 deficiency affect vasoconstriction and atherosclerosis in Ldlr-/- mice?
Answers are grounded in this paper and cite their sources.
SMC cholesterol efflux pathways suppress α1-AR-mediated vasoconstriction and bladder SMC transdifferentiation, but their deficiency does not impact atherosclerotic lesion size in this mouse model.
BACKGROUND: Smooth muscle cells (SMCs) regulate blood flow distribution via vasoconstriction mediated by α-ARs (α-adrenergic receptors). Plasma membrane cholesterol accumulation affects α 1 -AR signaling and promotes loss of SMC contractile markers in vitro. ABCA1 and ABCG1 (ATP-binding cassette transporter A1 and G1) mediate cholesterol efflux to HDL (high-density lipoprotein). ABCA1/ABCG1 show high expression in medial and low expression in intimal SMCs of atherosclerotic plaques. The role of ABCA1 and ABCG1 in SMC-mediated vasoconstriction and atherogenesis remains poorly understood. METHODS: We generated mice with SMC-specific Abca1/Abcg1 deficiency on the low-density lipoprotein receptor–deficient ( Ldlr − / − ) background by crossbreeding Abca1 fl/fl Abcg1 fl/fl Ldlr −/− mice with Myh11Cre ERT2 transgenic mice. To induce SMC cholesterol accumulation and atherogenesis, we fed Myh11Cre ERT2 Abca1 fl/fl Abcg1 fl/fl Ldlr −/− , Myh11Cre ERT2 Abca1 fl/fl Ldlr −/− , Myh11Cre ERT2 Abcg1 fl/fl Ldlr −/− , and Myh11Cre ERT2 Ldlr −/− mice Western-type diet for 16 weeks. RESULTS: Combined SMC-Abca1/Abcg1 deficiency increased vasoconstriction in aortic rings induced by the α 1 -AR agonist phenylephrine. Unexpectedly, SMC-Abca1/Abcg1 deficiency induced urinary bladder distension by >20-fold. This was reversed by the α 1 -AR antagonist tamsulosin, indicating its dependence on bladder neck SMC constriction. Moreover, SMC-Abca1/Abcg1 deficiency decreased contractile markers and increased macrophage and fibroblast markers in bladder SMCs, indicating SMC transdifferentiation. This was accompanied by free cholesterol accumulation and increased endoplasmic reticulum stress. SMC-Abca1/Abcg1 deficiency did not induce thoracic aorta SMC transdifferentiation, presumably due to increased cholesteryl ester accumulation and no endoplasmic reticulum stress in thoracic aorta SMCs. Surprisingly, SMC-Abca1/Abcg1 deficiency did not affect atherosclerotic lesion size or composition in the aortic root or brachiocephalic artery. CONCLUSIONS: We uncover a new role of SMC cholesterol efflux pathways in suppressing α 1 -AR–mediated vasoconstriction and bladder SMC transdifferentiation, decreasing urinary bladder distension. Our data may provide a mechanistic link for the association between urinary bladder distension and diabetes in humans, particularly because diabetes is associated with decreased cholesterol efflux. SMC-Abca1/Abcg1 deficiency did not affect atherosclerotic lesion size or plaque composition, presumably due to low expression of Abca1/Abcg1 in intimal SMCs.
No takes yet. Share an insight, caveat, or question.
Halmos et al. (2025) studied Atherosclerosis and urinary bladder distension. SMC-specific Abca1/Abcg1 deficiency vs. Control mice (Ldlr-/- background without combined deficiency) was evaluated on Urinary bladder distension and atherosclerotic lesion size. SMC-specific Abca1/Abcg1 deficiency in mice induced urinary bladder distension by >20-fold but did not affect atherosclerotic lesion size or plaque composition.
Synapse has enriched 10 related papers. Consider them for comparative context: